lopinavir has been researched along with Cross Infection in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Baden, LR; Morrissey, S; Rubin, EJ | 1 |
| Chan, KH; Chan, KS; Cheng, VC; Chu, CM; Guan, Y; Hung, IF; Kao, RY; Peiris, JS; Poon, LL; Wong, CL; Wong, MM; Yuen, KY | 1 |
1 trial(s) available for lopinavir and Cross Infection
| Article | Year |
|---|---|
Role of lopinavir/ritonavir in the treatment of SARS: initial virological and clinical findings.
Topics: Adult; Aged; Cross Infection; Disease Progression; Drug Therapy, Combination; Female; HIV Protease Inhibitors; Humans; Lopinavir; Male; Middle Aged; Odds Ratio; Pyrimidinones; Ritonavir; Severe Acute Respiratory Syndrome; Steroids; Treatment Outcome; Viral Load | 2004 |
1 other study(ies) available for lopinavir and Cross Infection
| Article | Year |
|---|---|
Audio Interview: New Research on Possible Treatments for Covid-19.
Topics: Adrenal Cortex Hormones; Anti-Inflammatory Agents, Non-Steroidal; Antiviral Agents; Betacoronavirus; Clinical Trials as Topic; Coronavirus Infections; COVID-19 Drug Treatment; Cross Infection; Diagnosis, Differential; Drug Combinations; Humans; Hydroxychloroquine; Infection Control; Influenza, Human; Lopinavir; Patient Care; Receptors, Virus; Respiration, Artificial; Ritonavir; SARS-CoV-2 | 2020 |